Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus

NCT04160988 is registered in ClinicalTrials.gov with Acer Being Health Inc. as lead sponsor.

NCT NCT04160988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04160988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus
Lead sponsor
Acer Being Health Inc.
Phase
Observational
Overall status
Completed
Start date
December 16, 2019
Completion date
May 11, 2020
Enrollment
703 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy